Combined Antiplatelets and Anticoagulants for Atherosclerosis: Insights from the COMPASS Study

Kelley Branch, MD, MS, and Jeffery Probstfield, MD, provide insight into the COMPASS study, discussing the objectives and primary outcomes, proven effective secondary prevention therapies and conclusions from the study.

Related Presenters

Kelley Robert Branch, MD, MS.

Kelley Robert Branch, MD, MS

Director of Cardiovascular Clinical Trials at the University of Washington, Seattle Associate Director of the Clinical Trials Service Unit

Kelley Robert Branch, M.D., M.S., is an associate professor in the UW Division of Cardiology. He is also the director of Cardiovascular Clinical Trials at the UW and associate director of the Clinical Trials Service Unit that facilitates ...

View full profile

Jeffrey Probstfield, MD, FACP, FACC, FESC.

Jeffrey Probstfield, MD, FACP, FACC, FESC

Professor of Medicine, Adjunct Professor of Epidemiology, School of Public Health Director, Clinical Trials Service Unit

In 1995, the Clinical Trials Service Unit (CTSU) in the Division of Cardiology was founded by the current CTSU Director, Jeffrey Probstfield, M.D.  Dr. Probstfield brought his years of experience in clinical trials training to direct the ...

View full profile

Related Videos